 Home > Medical News > Latest Medical News > AstraZeneca terminates development of Phase II/III COVID-19 vaccine AZD2816

AstraZeneca terminates development of Phase II/III COVID-19 vaccine AZD2816

 Last Update: 2022-03-02
 Source: Internet
 Author: User

Tags

manufacturing companies work

phase metabolism

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

AstraZeneca disclosed in its 2021 financial report that it has terminated the development of the new coronary pneumonia vaccine AZD2816

Mene Pangalos, Executive Vice President, Biopharmaceuticals R&D, AstraZeneca, said: "AZD2816 is not significantly different in immunogenicity from the marketed vaccine Vaxzevria and there is no need to switch from one vaccine to another

Vaxzevria uses replication-defective simian adenovirus ChAdOx1 as a vector, containing the full-length spike protein of SARS-CoV-2 and a TPA leader sequence

AZD2816 is an improved vaccine against the Beta variant, developed using the same adenoviral vector technology platform as Vaxzevria

In addition, AstraZeneca has also deployed a long-acting antibody cocktail therapy Evusheld (tixagevimab + cilgavimab) in the field of new coronary pneumonia

This is a wake-up call for Moderna and Pfizer

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.